Category: Johnson & Johnson
A jury begins deliberations in the 1st trial over DePuy Orthopaedics' Pinnacle metal-on-metal hip implant.
Here's a look at some of the top regulatory stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit
, Becton Dickinson & Co.
, DePuy Synthes
, GenCell Biosystems
, Johnson & Johnson
, Kimberly-Clark Worldwide Inc.
, MAKO Surgical Corp.
, Stryker Corp.
, Valeant Pharmaceuticals
, 3M Corp.
, Allergan Inc.
A federal judge bars sales of Johnson & Johnson unit Ethicon Endo-Surgery's Harmonic Ace +7 surgical shears in a patent infringement lawsuit brought by Covidien.
More than 2½ years after it spent $21.3 billion on Synthes, Johnson & Johnson continues to take hefty charges on integrating the orthopedics company into its DePuy franchise.
Johnson & Johnson's 2nd-quarter sales top forecasts, prompting the medical product giant to raise its full-year earnings guidance.
Medical device and pharmaceutical companies paid out $3.5 billion to doctors and hospitals during the last 5 months of 2013, according to new data from the Centers for Medicare & Medicaid Services, including a $30 million spend by Medtronic.
NEW YORK (Reuters) – U.S. doctors and teaching hospitals received $3.5 billion from medical device makers and pharmaceutical companies in the last 5 months of 2013, according to the most extensive data trove on such payments ever made public.
More and more patients are reportedly hacking into their glucose monitors to add functions like online data display and continuous glucose monitoring.
MASSDEVICE ON CALL — More and more patients are hacking into their glucose monitors to add functionality, with medical device companies lagging behind as they work their own improvements through the FDA, according to the Wall Street Journal.